Search

Search Constraints

You searched for: Author/Creator Kornblau, Steven M.

Search Results

1. A phase II study of omacetaxine mepesuccinate for patients with higher‐risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents. Issue 1 (15th November 2018)

4. Augmented Berlin‐Frankfurt‐Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL). Issue 23 (17th July 2014)

5. Augmented Berlin‐Frankfurt‐Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL). Issue 23 (17th July 2014)

6. Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF‐κB subunit RelA. Issue 2 (17th November 2021)

7. Design, development, and validation of a high‐throughput drug‐screening assay for targeting of human leukemia. Issue 4 (25th October 2013)

8. Design, development, and validation of a high‐throughput drug‐screening assay for targeting of human leukemia. Issue 4 (25th October 2013)

9. Final results of a single institution experience with a pediatric‐based regimen, the augmented Berlin–Frankfurt–Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper‐CVAD regimen. Issue 8 (30th June 2016)

10. Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia. (21st October 2016)